International Prevention Research Institute (iPRI), Lyon, France
The International Prevention Research Institute (iPRI) was founded by a group of epidemiologists and biostatisticians highly experienced in the field of chronic disease prevention. iPRI is a new concept in biomedical research combining a thorough, high-level, academic approach coupled with a practical focus on providing clear information about evidence-based individual and population-based prevention strategies. It serves as an independent authoritative source of advice on critical risk issues and as a high-level training centre in all aspects of Prevention Research. All senior partners hold academic positions at different Universities around the world.
iPRI scientists have a long experience in the coordination and conduct of international case-control and epidemiologic studies, especially in cancers and diabetes. Coordination activities especially at EU level are another corner piece (EUROCAN+PLUS; European Code Against Cancer; European Cancer Observatory). They have been leading projects on descriptive epidemiology of cancer and other chronic diseases, including cancer maps, series of reports on cancer mortality in Europe, and international surveys of tobacco smoking and other chronic disease risk factors. iPRI has an extensive programme of Public Health research in lower resource countries which complements its activities in higher resource countries. An additional pillar in iPRIs work experience is in the field of governance and internationalization of biobanking (iPRI was responsible for Global integration with the EU FP7 fundded BBMRI project).
Profile of staff members
Philippe Autier is a well known epidemiologist with more than 25 years of experience in developing and managing cohort and case-control studies globally. Peter Boyle, Member of the National Academy of Scotland, Fellow of the Academy of Medical Sciences (UK) and Honorary Member of the Hungarian Academy of Sciences, is a worldwide accepted expert in the field of chronic disease prevention; in this project he shall be responsible for the Tasks in WP1. Mathieu Boniol is an experienced biostatistician; he
will be involved in the statistical tasks of WP1. Markus Pasterk is experienced in research coordination and scientific administration, especially within EU projects. He will support the tasks of WP1. iPRI will be involved in the tasks: data integration, data standardization and statistical analyses.
Recent publications relevant to the project
1. . La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P and Levi F. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Annals Oncology 2009 Nov 30. [Epub ahead of print]
2. Yuille M, van Ommen GJ, Bréchot C, Cambon-Thomsen A, Dagher G, Landegren U, Litton JE, Pasterk M, Peltonen L, Taussig M, Wichmann HE, Zatloukal K. Biobanking for Europe. Brief Bioinform. 2008 Jan;9(1):14-24.
3. Boyle P, Chapman CJ, Holdenrieder et al. Clinical validation of an autoantibody test for lung cancer diagnosis. J Clin Oncol (provisionally accepted)
4. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007 Mar;18(3):581-92. Epub 2007 Feb 7.